Adoption allows ICON to take full advantage of the Medidata "Data Experience," leveraging AI to unify data sources, standardize outputs, and reduce reconciliation efforts NEW YORK, March 20, 2025 ...

Sapient Bioanalytics is a biomarker discovery organization that provides multiomics services for metabolomics, lipidomics, and proteomics data ... clinical problems.” Quantum-Si’s next ...

DUBLIN, January 30, 2025--(BUSINESS WIRE)--ICON ... and data privacy standards in the deployment of new solutions. The latest solutions to be launched are: iSubmit, which automates the clinical ...

We recently compiled a list of the Top 8 Trending AI Stock Updates On Wall Street Today. In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ:ICLR) stands ...

“Our data presentations ... 2 and Phase 3 clinical trials with a strategic focus on two pan-tumor priority programs: investigational mRNA cancer immunotherapies and the next-generation ...

Amy Abernethy, M.D., Ph.D., left Verily earlier this year as its chief medical officer and has now teamed up with a long-time colleague to launch an initiative that takes a new approach to ...

“ICON leads in risk-based quality management, integrating Data Management and Central Monitoring teams in our Clinical Data Science group. To meet growing data demands and customer expectations ...

MAINZ, Germany, April 24, 2025 -- BioNTech SE (Nasdaq: BNTX, "BioNTech” or "the Company”) will present data ... clinical trials with a strategic focus on two pan-tumor priority programs: ...

The integration of Clinical Data Studio into ICON’s service offerings helps unlock the full potential of the Medidata Data Experience, merging information from both Medidata and non-Medidata sources, ...